Avricore Health offers products and services to empower and educate pharmacists Government action on drug pricing has had unintended consequences for community pharmacies and health care Avricore Health’s offering helps pharmacists grow revenues, enhance role in customer care HealthTabTM allows quick access to health biomarkers, personalized genomic information The Government
Government action on drug pricing has had unintended consequences for community pharmacies and healthcare Avricore Health’s offering helps pharmacists grow revenues, enhance role in customer care HealthTab™ allows quick access to health biomarkers, personalized genomic information The Government of Canada’s recent actions to take costs out of the health care
Avricore Health Inc. Advisory Board Welcomes Mark Zhou Pharmacy practice specialist and McKesson representative brings talent and expertise to Avricore’s strategic development and client education team Vancouver, March 18, 2019 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is very pleased to announce that Mark Zhou will join
March 15, 2019 – Avricore Health Inc. (“AVCR”), is pleased to announce that further to its news release dated February 13, 2019, it has closed a non-brokered private placement of 4,206,435 common shares (“Common Shares”) of the Company at a price of $0.07 per Common Share for gross proceeds of
Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) announces that it has issued a total of 125,081 common shares of the Company to Lampyon Canada Inc., in consideration for services rendered pursuant to the terms of a Service Agreement entered into with Avricore Health on April 10th, 2018, and amended on
Avricore Health Inc. (“AVCR”), announced today a non-brokered private placement of up to 14,285,714 common shares at a price of $0.07 per common share for gross proceeds of up to $1,000,000 (the “Offering”). The Company may pay a finder’s fee on the Offering within the amount permitted by the policies
Avricore Health Inc. (TSX-V: AVCR) (OTCQB: AVCRF) (“Avricore Health” or the “Company”) Dear Shareholders: Thank you for your continued support of Avricore Health. We know this market has been challenging for our industry and our shareholders alike; however, we have had an exciting year and are poised for success in
Avricore Health Inc. Advisory Board Welcomes Hector Bremner Communications professional and former advisor to BC Deputy Premier and Vancouver City Councillor will support Strategic and Government Affairs Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is very pleased to announce that Hector Bremner will join the company’s Advisor Board and support
Former Commissioner with the Pharmaceutical Advertising Advisory Board (PAAB) will support strategic marketing practices and ensure strategic direction and regulatory practices. Vancouver, BC / TheNewswire / January 29, 2019 – Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is very pleased to announce that Ray Chepesiuk will join the company’s Advisory
VANCOUVER, BC, December 18, 2018 – Avricore Health Inc. (TSXV: AVCR) (“Avricore Health”) is pleased to announce that it has signed a Letter of Intent (LOI) with Molecular You Corporation (“Molecular You”) to distribute Molecular You’s pharmacogenomic tests designed to ensure safe and effective use of cannabis by customers in
